View all veterinary jobs
VetNurse.co.uk publishes a curated feed of veterinary nursing news for registered veterinary nurses (RVNs), students (SVNs) and veterinary nursing assistants, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest or professional significance — filtering out noise so busy veterinary nurses can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, referral and specialist settings, with a focus on issues affecting veterinary nurses in clinical and professional roles.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetNurse news by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
In short, it’s a system which gives clients a breakdown of the options you have recommended, with an explanation of the procedure or treatment, potentially the pros and cons, and the price.
When time permits, this allows the client to consider their options at home, on their own, with the information in front of them, taking away the pressure that sometimes comes with having to make these decisions in front of a veterinary professional.
The system works as a standalone web-based service at present, but integrations with VetIT and Lupa are in development.
Practices can configure the software with their own information about treatment and procedures, but VetConsent has also teamed up with Visiocare and Vetlexicon to provide graphically rich material to help the client understand even better.
The service costs £40 per vet per month.
Chief Veterinary Officer, Nick Lloyd MRCVS said: “We’re confident that the time-savings alone will more than cover the cost of the service, but even more importantly, it improves the service you offer clients and ensures that you’ve covered all the bases in getting informed consent.”
https://vetconsent.com
Zoetis says AI Masses delivers fast, accurate, in-clinic screening of common lymph node and skin/subcutaneous masses in minutes, making Vetscan Imagyst the most capable veterinary AI analyser in the world.
AI Masses uses an algorithm to identify and classify common skin/subcutaneous mass and lymph node aspirates at the point of care.
At additional charge, for added diagnostic confidence, Zoetis also offers expert clinical pathologist reviews via Digital Cytology and Add-on Expert Review within hours.
Abhay Nayak, President, Global Diagnostics at Zoetis said: “By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets.
https://www.zoetisdiagnostics.com/uk/point-of-care
Dexmedocord is a dexmedetomidine 0.5 mg/ml solution for injection for dogs and cats and is available through all major UK veterinary wholesalers.
It is indicated in cats and dogs for non-invasive, mildly to moderately painful procedures and examinations requiring restraint, sedation and analgesia.
In dogs, it is also indicated for deep sedation and analgesia in concomitant use with butorphanol for medical and minor surgical procedures, and as a premedication in dogs and cats before induction and maintenance of general anaesthesia.
Dexmedetomidine is the active dextrorotatory enantiomer of medetomidine.
Bob Ferguson, Director of Animal Health at Accord Animal Health, said: "Veterinary practices need trusted products backed by accessible pricing and reliable supply."
"Dexmedocord marks an important milestone as our first POM-V pharmaceutical launch in the UK and reflects the established expertise and strong heritage in high-quality pharmaceuticals that we bring through the wider Accord group."
accordanimalhealth.com
Lenivia is the first long-acting canine anti-nerve growth factor monoclonal antibody therapy administered three-monthly.
It acts via its binding to nerve growth factor (NGF), a recognised mediator of pain and inflammation.
Julia von Gablenz, Regional President, Europe & Middle East of Zoetis, said: "Lenivia's approval marks a meaningful milestone in our continued innovation for canine osteoarthritis pain."
She added: "With Lenivia's approval, we're proud to bring UK(GB) veterinary professionals a new, long-acting option that can help alleviate osteoarthritis-associated pain and support sustained comfort with a single injection."
The new library provides images of companion and farm animals with the purpose of helping animal health teams find the right images quickly, and with confidence in their clinical accuracy for appropriate use.
Toby Trimble, founder of Trimble Group, said: "We repeatedly saw a common issue in the veterinary sector of inadequate images and teams were having to spend significant amounts of time searching for usable images.
"To remedy this, we have created the Animal Health Image Library.
"Every image is clinically accurate, and features a mixture of breeds, signalments and scenarios.
"Furthermore we have clearly categorised images into categories which makes finding the right image a quick and easy process.
"We truly believe this resource will aid both those working in the industry creating content, and consumers who will benefit from seeing accurate imagery.”
www.vetimages.com
If adopted, the move would end the RCVS's 182-year role as regulator of the veterinary profession.
In its report, "A sustainable veterinary workforce", the committee said the Government should separate the RCVS's professional leadership role from any regulatory functions within the veterinary profession, creating a new independent body that can oversee the expanded role of a reformed Act.
The report argued that the current system of self-regulation makes the veterinary sector an outlier, pointing towards professions such as medicine and law where regulatory functions have been separated from professional bodies.
It added that self-regulation is increasingly unsuitable for a profession where vet practices and services are coming under the ownership of corporate entities and the management of non-vets.
The recommendation sits within a wider package on veterinary workforce pressures, veterinary education, Competition and Markets Authority remedies and reform of the Veterinary Surgeons Act.
On workforce, the report said pressures in the profession are no longer driven primarily by an overall shortage of qualified individuals, but by challenges in retention, distribution and alignment with specific roles.
It recommended that Defra should, within six months, commission a sector-wide review of retention challenges across the profession.
The report also said the Home Office, in collaboration with Defra, should review the Skilled Worker Visa salary thresholds for veterinary roles by early 2027.
On veterinary education, the committee said the current funding model is not sustainable and recommended a full review of funding within the next Spending Review.
It also said the Government should ensure the CMA's remedies are fully rural proofed, and that the CMA, in partnership with the RCVS, should establish a monitoring framework by September 2027.
The RCVS welcomed the majority of the recommendations but said the idea of establishing a new veterinary regulator "seems to be based on a fundamental misunderstanding of the current role and functions of the College."
In a statement, the College added: “The report appears to assert that this reform is necessary because the functions of the RCVS are in conflict with one another, or that it is otherwise undesirable for these functions to be carried out by one organisation.
"Comparison with the legal sector – in which the regulatory and representative functions of professional bodies were separated by statute in 2007 – strongly implies that the committee considers the same reform necessary in the veterinary sector because the RCVS has similarly conflicting functions, which it does not, and suggests a conflation between professional leadership and representation.
“Furthermore, the report fundamentally misunderstands the concepts of self-regulation and regulatory independence.
"In the context of modern regulatory regimes, 'self-regulation' refers to the independence of a regulator from government, not whether a profession makes rules for itself. In this sense most professional regulators, including the General Medical Council, are both self-regulating and independent.
“The press release accompanying the report is more explicit on these points, arguing that the establishment of a new regulator would allow the RCVS to “specialise in continuing to represent the profession’s interests.”
"To be clear, the RCVS does not represent the interests of the veterinary profession as a whole, nor those of the individual veterinary professionals we regulate.
“While it is true that the RCVS is currently both a statutory regulator and a professional leadership body, we carry out our statutory regulatory function in the public interest under the Veterinary Surgeons Act 1966, and we carry out our professional leadership function in the public interest in line with the objectives in our Royal Charter.
"There is therefore no conflict between the two functions; indeed, they are complementary, allowing us to take a holistic approach to setting, maintaining and advancing veterinary standards.
“Furthermore, our Royal Charter has enabled us to innovate and plug gaps in our aging legislative framework, for example through regulating veterinary nurses and providing quality assurance of veterinary care through our Practice Standards Scheme.
"Far from detracting from or conflicting with our regulatory function, our professional leadership function, underpinned by the Charter, has reinforced our ability to take action in the public interest where we may not have statutory powers to do so.
“In relation to any suggestion that the RCVS should no longer be the veterinary regulator because it is unduly influenced by the profession through its governance arrangements, we would emphasise that the College has for some time been advocating for legislative reform that would replace its governing Council with a fully appointed board with lay parity, which would remove any risk, real or perceived, of the profession setting and marking its own homework.
"We are pleased that Defra has adopted this recommendation in full as part of its proposed reform of the Veterinary Surgeons Act 1966.”
https://publications.parliament.uk/pa/cm5902/cmselect/cmenvfru/270/report.html
Analysis
The recommendation to create a new veterinary regulator is arguably the most significant proposal in the report, yet the committee’s case for such a fundamental change appears relatively thin.
The report argues that regulation should be separated from professional leadership, bringing the veterinary profession into line with sectors such as medicine and law. It also points to increasing corporate ownership of veterinary practices and the need to maintain public confidence.
However, the report does not provide evidence that the current regulatory model is failing, nor does it explain why reform of the RCVS itself would not achieve the same objective.
The result is that the recommendation appears to rest more on an ideological preference for separating professional leadership from regulation than on evidence that the existing model is producing poor outcomes.
Photo: EFRA committee chair Alistair Carmichael, whose committee has called for an end to veterinary self-regulation.
The study1 was led by Dr Zoe Davies, a former Postdoctoral Researcher at the RVC, supervised by Jim Usherwood, Professor in Locomotor Biomechanics at the RVC, and co-authored by Aimee Savage, who was an RVC undergraduate at the time.
It involved six dogs with forelimb amputations and six with hindlimb amputations recruited from across the UK through the RVC's social media channels.
Using a 3D motion capture system and force plates in the RVC's Structure and Motion Laboratory, researchers analysed how the dogs adapted their bodies at different speeds.
At higher speeds, the dogs used a gallop-like gait similar to that seen in four-legged dogs.
At slower speeds, the dogs adopted two different movement strategies.
One involved a slowed-down version of the gallop.
The other involved a gait in which the pair of remaining limbs moved in a walking pattern, while the single remaining limb contacted the ground more than once during each stride.
When analysing forces acting on the limbs, the researchers found that forelimb amputee dogs placed around 50% of their bodyweight through their single remaining front limb, whereas weight in hindlimb amputee dogs was distributed more evenly across their three remaining limbs.
The RVC said the research provides a foundation for future work into rehabilitation and mobility support for canine amputees and may also inform the development of adaptive legged robots capable of responding to limb loss.
https://royalsocietypublishing.org/rspb/article/293/2069/20253159/481426/Locomotion-on-three-legs-the-tripedal-gaits-of
Reference
The programme features more than 30 speakers from the UK and overseas covering ECC anaesthesia, advanced surgical techniques, oncology, diagnostics, sepsis, nursing care and complex case management.
This year's keynote speaker is Professor Patrick Pollock, Professor at the University of Glasgow, and confirmed speakers also include Professor Kate Hopper, Associate Professor Claire Sharp and Marlaina Hrosch.
The programme includes practical workshops, case-based discussion and non-technical sessions on communication, teamwork and wellbeing.
The event includes access to session recordings after the congress, allowing delegates to revisit content.
Tickets are available now.
www.vets-now.com/congress-2026
DuOtic contains terbinafine 10 mg and betamethasone 1 mg and is supplied in pre-measured single dose 1.2 g tubes.
One tube should be applied per ear canal by a vet and repeated after seven days.
Jamie Walker MA VetMB MRCVS, veterinary technical manager at Dechra, said: "DuOtic has been available in Ireland and Northern Ireland for some time and feedback from vet professionals has been positive, both logistically as no refrigeration is required, but also practically as dog owners have appreciated the product being vet-applied, reducing the stress associated with treatment.
"Some owners also appreciated the targeted nature of the treatment in the broader context of antimicrobial stewardship."
The annual survey captures data including basic salaries, bonuses, dividends, overtime, and benefits such as accommodation, company vehicles, car allowances and pension contributions.
SPVS is inviting responses from everyone working in the veterinary sector, including veterinary surgeons, nurses, practice managers, support staff, and those working in industry or non-clinical roles.
The main findings will be published in a summary report, which will be made freely available to all participants who provide their email address at the end of the survey.
SPVS members will be able to access the full report, including detailed analysis and expert commentary.
Participants will also have the chance to enter a prize draw to win a Bose SoundLink Plus portable speaker.
https://www.smartsurvey.co.uk/s/3YMX1O/
LUMOS delivers case-based learning through Foundation, Intermediate and Advanced modules created and reviewed by qualified veterinary professionals.
The platform allows users to complete learning in short sessions, saves progress automatically, and lets learners pause and resume training without losing their place.
Learners can track individual module completions and work towards BSAVA LUMOS Bronze, Silver and Gold Awards.
LUMOS also includes community forums for peer interaction.
It is available to all vets and veterinary nurses, with BSAVA members receiving a 25% discount on all modules.
Pricing ranges from £75 to £400, depending on module level and audience.
Stacy Woodman, Interim CEO at the BSAVA, said: "We are delighted to launch BSAVA LUMOS, our innovative online learning experience developed for small animal vets and veterinary nurses.
"This marks a significant step forward in how the BSAVA supports learning, professional development, and career progression across the small animal veterinary profession."
"Our team of CPD experts, volunteers, and support staff have worked tirelessly to bring LUMOS to life, which has been deliberately designed with flexibility and relevance at its core in response to the changing needs of the profession."
https://www.bsava.com/education/lumos
Krka says Robexera injectable acts within an hour, has a 24-hour duration and that its high COX-2 selectivity reduces wider systemic impact.1
The company says that in cats, the perioperative case is particularly strong, pointing to research which it says showed robenacoxib to have the best proven safety profile in cats of all NSAIDs.1
Krka adds that it is also highly effective in reducing post-operative pain, with evidence of superior efficacy to meloxicam,2 and a proven anaesthetic-sparing effect during feline surgery.3
Will Ridgway, Head of Animal Health at Krka UK, said: “Practices want product assurance and commercial value. As a bioequivalent to the originator product,4 Robexera injectable delivers both."
https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_3090863.PDF
References
For the research, published in Osteoarthritis and Cartilage, the team studied osteoarthritic tissues from dogs with osteoarthritis treated with total hip replacement surgery at the RVC's Queen Mother Hospital for Animals, using ultra-high-resolution micro-computed tomography to map the entire femoral head in three dimensions.
Using this technique, as opposed to more localised analysis previously conducted on human samples, researchers identified that different areas of the femoral head simultaneously responded differently.
In particular, the findings revealed that in the earliest stages of osteoarthritis, the inner regions predictably change their bone structure pattern, allowing early identification of osteoarthritis.
As the disease progresses, the dense layer of bone immediately below the joint surface becomes more porous in proportion to the increasing severity of osteoarthritis, distinguishing mild from severe changes.
The researchers say that the next step is to match these changes with clinical scans to develop improved non-invasive approaches to assessing joint health at much earlier stages of disease.
Professor Richard Meeson, Professor of Orthopaedics at the RVC, and senior author of the paper, said: "Osteoarthritis is a devastating disease affecting both people and our pets.
"Every day in our orthopaedic referral clinic, I see dogs suffering from its severe effects.
"What is truly exciting is that through our clinical work, we can transform the lives of dogs through hip replacement surgery, and we have also been able to drive forward pioneering research at the RVC.
"This research has provided new insights into the disease and, crucially, brings us closer to diagnosing osteoarthritis at a much earlier stage."
The study, led by Svenja Springer from the Department of Interdisciplinary Life Sciences, Messerli Research Institute, University of Veterinary Medicine Vienna, used an online questionnaire in March 2022 to investigate dog and cat owners in Austria, Denmark and the UK, with a final sample of 2,117 owners.
The survey found that differences in insurance uptake across income groups were seen only in the UK, where 65.6% of owners in the high-income group (more than £44,800 a year) had insurance compared with only 35.1% in the low-income group (less than £22,400 a year).
Overall, 51.5% of UK households in the sample had insurance and 48.5% did not.
Among owners without insurance, UK respondents were much more likely to say policies were too expensive (48.9%) compared with 28.1% in Denmark and 29.9% in Austria.
However, when it comes to how much owners are prepared to spend on veterinary treatment, the paper concludes that emotional attachment to a pet was the most important factor, over and above income or insurance status.
Nevertheless, only around 20% of UK dog owners said they would spend over £3000 of their own money — that is, over and above any insured sum — on treatment.
Some 24.8% of the owners of uninsured dogs and 34.7% of the owners of insured dogs said they would spend £101 to £1000 of their own money.
Around 11% said they would spend £1001 - £3000 and 19.8% of insured vs 27.1% of uninsured said they didn't know.
In the first report1, which concerned an outbreak on a busy competition yard after the introduction of a new horse without an isolation period or pre-movement blood ELISA screening for recent S. equi exposure, no horses developed signs of strangles after the second vaccination with Strangvac was administered.
In the second report2 strangles was confirmed in three unvaccinated and unwell horses and 17 healthy horses on the same yard were subsequently vaccinated with Strangvac.
Blood samples in this group of vaccinated horses demonstrated that over half had recent exposure to S. equi, despite which, none of them developed strangles.
Bex Glasgow, veterinary surgeon and equine veterinary advisor at Dechra said: “Strangles vaccination, alongside good biosecurity measures, are essential tools in disease prevention and recent studies have also demonstrated its protective effect during outbreak situations.”
Strangles Awareness Week, which is supported by Dechra, takes place from 4 to 10 May 2026.
The initiative is aimed at increasing screening throughout the year and helping identify cats living with untreated hypertension.
Challenge 20 encourages vet professionals to screen and record over 20 new feline blood pressure measurements per practice in cats at increased risk, including those with concurrent diseases such as chronic kidney disease and hyperthyroidism, those with signs of target organ damage and all cats over seven years of age.
After the feedback session, the Ceva vet will work with the practice to identify any training requirements and create a tailored plan, before repeating the challenge to track progress and fine-tune the approach.
Ceva is also providing marketing materials focusing on hidden hypertension and concurrent disease, including a cat owner poster, leaflet, owner email content and a social media toolkit.
The company is also offering dedicated time and guidance from its territory managers to help implement better screening protocols.
A feline hypertension bitesize video CPD series is also available at the Ceva Academy: https://ceva.vbms-training.co.uk
Andrew Fullerton, senior product manager at Ceva, said: "Over 1,200 cats were screened during Ceva's 2025 feline hypertension campaign and a third of them were identified as hypertensive1."
He added: "We continue to encourage vet professionals to test for feline hypertension in all cats over seven years of age, with a particular focus on those more susceptible to high blood pressure, such as those with concurrent diseases and those with signs of target organ damage through our Challenge 20 initiative."
https://easethepressure.co.uk
The clinical team at the RVC analysed anonymised clinical data from dogs from the UK, Europe and the USA undergoing mitral valve repair at the Queen Mother Hospital for Animals at the RVC.
One study evaluated the anaesthetic management and outcomes of 176 dogs undergoing surgery, focusing on complications during and around the time of anaesthesia1.
The second study assessed 66 dogs to identify features on heart scans that could help predict whether the heart would remain enlarged after surgery2.
The findings showed that mitral valve repair is associated with significant intraoperative and postoperative risks.
Longer cardiopulmonary bypass duration was associated with increased risk.
Dogs with greater pre-surgical heart enlargement and higher body weight were more likely to have persistent left heart enlargement after surgery.
Close perioperative monitoring and rapid-response protocols were found to be essential in managing anticipated complications.
The study also found that recovery outcomes vary, meaning individual patient factors must be considered when advising owners.
Finally, the research demonstrated that most beneficial changes in heart size, known as reverse remodelling, occurred within the first three months after surgery.
Professor Dan Brockman, Professor in Small Animal Surgery and Director of the Cardiothoracic Surgery Service at the RVC, said: "Establishing and maintaining open heart surgical capability at the RVC has been both the most challenging and the most rewarding activity of my 36 years as a specialist small animal surgeon.
"Our team are rightly proud of what we have achieved, but we all know that the route to even greater consistency of results lies in the constant process of reflection, refinement and improvement in every aspect of what we do."
The RVC is currently the only centre in the UK offering this specialist surgical procedure.
https://www.rvc.ac.uk/small-animal-vet/specialist-referrals/advanced-techniques/cardiothoracic-surgery/mitral-valve-disease
The software is designed to help practice managers plan rotas across roles including vets, nurses, receptionists and support staff.
Agilio says that iTeam Rota can help practices spot staffing gaps earlier, manage leave, sickness and CPD on a single screen, and give team members access to an up-to-date rota from any device.
The company also says the system can support repeatable shift patterns and multi-site rota management.
Emma Barnes, Managing Director of Emerging Markets at Agilio (pictured), said: "Anyone who's ever wrestled a rota in a spreadsheet knows that sinking feeling when you've just got it straight, and then someone changes their hours or calls in sick and you're back to square one.
"It's a constant firefight, and never a finished job."
"We've built iTeam Rota specifically for veterinary practices because their staffing challenges are unlike other sectors, and generic tools simply don't cope with that.
"Practices are dealing with more part-time roles, flexible working patterns and multi-site teams, and need a rota system that mirrors how their people actually work, and not the other way round."
agiliosoftware.com/veterinary/iteam-rota
The six-month group coaching scheme is for experienced equine vets and vet nurses and is delivered through monthly online group coaching sessions.
Applications for the 2026 cohort are open until Wednesday 27 May 2026, and 25 places are available.
The coaching team includes Lucy Grieve, Claire Goodban, Kate Blakeman and Gemma Dransfield—all veterinary professionals with coaching training—now joined by vet nurse Rosina Lillywhite to give dedicated support for veterinary nurses.
Kate Blakeman, BEVA vice president, programme founder and a Back in the Saddle coach, said: "Coaching is becoming increasingly recognised as a key factor in building professional resilience, restoring confidence and supporting career transitions."
Rosina Lillywhite said: "Back in the Saddle is about creating the time and space for both vets and veterinary nurses to step back, reflect and move forward with renewed confidence."
"Whether someone is navigating a period of change or simply reassessing their direction, the programme offers structured support, practical strategies and the reassurance that they're not alone in the challenges they're facing. It's a really valuable opportunity to reconnect with your career and regain a sense of purpose within the profession."
https://www.beva.org.uk/Career-support/Vets/Back-in-the-Saddle
The model was trialled at the group's Rotherham practice where it has introduced advanced soft tissue surgery, 128-slice CT scanning, orthopaedics and spinal surgery, cardiac scanning and ophthalmology.
To offer the service, the group has invested £280K in post-graduate qualifications for its vets and £130k in equipment over the past 18 months.
The Pet Vet Says that not only does the ‘First Opinion Plus’ model expand the group’s ability to serve more pets in their communities, it has also boosted recruitment and retention of clinical colleagues by offering rewarding technical career pathways in addition to traditional leadership routes.
Emily Chapman, Area Manager at The Pet Vet, said: “The implementation of the ‘first opinion plus’ model at The Pet Vet Rotherham has transformed our offering to customers and referring surgeries.
We’ve taken that success and tailored it for each of our 12 surgeries, so every local community we serve benefits from the best of both worlds: trusted first opinion care and advanced services under one roof, as well as a stable and motivated team of colleagues that are supported in pursuing their clinical passions.”
www.thepetvet.co.uk/careers.
Giles is the professor of molecular neuroendocrinology at the Medical Research Council Metabolic Diseases Unit and scientific director of the Genomics/Transcriptomics Core at the University of Cambridge.
He is a well-known broadcaster thanks to his appearances on programmes such as BBC’s ‘Horizon’ and ‘Trust me, I’m a Doctor’ and author of two books: Gene Eating: The Story Of Human Appetite and Why Calories Don't Count.
He also hosts the podcast Dr Giles Yeo Chews The Fat.
Giles and his colleagues at the University of Cambridge recently identified a genetic mutation in Labrador retrievers that significantly increases their propensity for obesity and food motivation.
This mutation, a 14-base pair deletion in the POMC gene, disrupts the production of beta-MSH and beta-endorphin, hormones involved in regulating appetite and energy balance.
The study found this mutation is present in about 25% of Labradors and 66% of flat-coated retrievers, and is also more common in assistance dogs than pet Labradors.
Giles' lecture: "The genetics of obesity: Can an old dog teach us new tricks?" will lay out the evidence for a genetic basis to body weight and explore the role of the leptin-melanocortin pathway in both human and dog obesity, and its conservation through evolution.
Giles said: “It is clear that the cause of obesity is a result of eating more than you burn.
"It is physics.
"What is more complex to answer is why some people eat more than others?
"Differences in our genetic make-up mean some of us are slightly more hungry all the time and so eat more than others.
"I will highlight the fat-sensing 'leptin-melanocortin' pathway, as a key appetite control circuit.
"Not only is the pathway conserved in all mammals and many higher vertebrates, but genetic disruption of the pathway as an evolutionary strategy to influence feeding behaviour has also been conserved. In contrast to the prevailing view, obesity is not a choice.
"People who are obese are not bad or lazy; rather, they are fighting their biology.”
British Veterinary Association President Elizabeth Mullineaux said: “I’m sure our BVA Congress delegates will appreciate both Dr Yeo’s scientific knowledge and his dynamic delivery style and I’m personally looking forward to learning more about this exciting topic.”
https://london.vetshow.com
This, the company says, makes Simparica Trio the only oral moxidectin that is licensed to treat A.vasorum in dogs in the UK.
Louise Longstaff, National Veterinary Manager at Zoetis UK said: “The last time a product was licensed for the treatment of lungworm in the UK was some time ago, so this is an especially important development.
"Simparica Trio offers a new licensed route of administration for lungworm treatment in dogs, giving vets another option to that which is currently available.
"It enables them to tailor treatment based on their patient’s needs while still prescribing within the cascade.”
Simparica Trio is a chewable monthly tablet for dogs containing sarolaner, moxidectin and pyrantel.
It kills fleas and ticks, treats mites, roundworm and hookworm, prevents and treats lungworm and prevents heartworm disease.
https://www.noahcompendium.co.uk/?id=-485011
The College wants more vets to come and share their ideas and insights into how the role of the veterinary nurse can be strengthened within the team, particularly in the light of data gathered from the RCVS’s 2024 VN Vision workshops which showed that many nurses believe their skills and capabilities, and the scope of tasks that can be performed within the current legal framework, are not fully used.
The first two events, in South Wales and Belfast, were well-attended by veterinary nurses, but only about 10% of attendees were vets who arguably have the most to gain by sharing ways of enabling nurses to perform a more central role and relieve some of their workload.
There are four more events coming up:
RCVS Director of Veterinary Nursing, Julie Dugmore, said: “Last year’s VN Vision events focused specifically on veterinary nurses and resulted in some truly inspiring insights. Now, in this new series of events, we’re taking the next step, and need to get the wider practice team involved in order to understand how strengthening the VN role will feed into team dynamics and the professions as a whole.
“Our latest VN Vision events will play a key role in helping us to define long term goals, identify the practical steps needed to achieve them, and determine how success will be measured and shared with the wider public. To make it happen, we need voices from vets, practice managers, support staff, and VNs alike.”
The VN Vision workshops are free to attend, informal, informative and made up of small groups.
Supper will also be provided for the evening sessions, and lunch for the London day workshops.
https://www.eventbrite.com/cc/vet-nursing-vision-events-3253639
Senior educators came from both UK and international veterinary and nursing schools to discuss and agree approaches to teaching contextualised care in first opinion practice for the first time.
The workshop aimed to give delegates an understanding of what contextualised care is and why it is important.
It also covered the types of clinical training settings that are conducive to supporting contextualised care learning.
Delegates then discussed the challenges associated with contextualised care learning in community-based clinical training settings.
They included: perceived conflicts between educational and commercial interests, a lack of previous formal teaching of contextualised care (during education), and the absence of established culture (and experience) of undergraduate teaching in clinical practice.
Workshop co-presenter and CVS’ Equine Development Lead Charlotte Sinclair, said: “Most veterinary graduates will enter primary care practice upon graduation and we know the majority of new graduates and employers agree that graduates are not prepared to practice contextualised care. The consequences of not being prepared include a tension between presumed ‘gold standard’ and the realities of practice, stress and moral distress.
“We hope that our landmark workshop will go some way towards helping trainers to support graduates in developing authentic communication skills, building client rapport, creating shared decision making, and being outcome focused. As true contextualised care relies on all of these skills.”
The guidelines, which are the result of a collaboration between veterinary dermatologists, clinical microbiologists and other specialists, are designed to reduce inappropriate antimicrobial use and help canine welfare.
The team conducted an evidence review and built a consensus of recommendations, combining scientific evidence with real-world insights.
The new guidelines are supported by the ISCAID (International Society for Companion Animal Infections) and provide veterinary practitioners with guidance on the diagnosis and investigation of canine bacterial skin infections.
The guidelines offer recommendations for when antimicrobials should be considered, and which classes of antimicrobials are most appropriate to choose from.
As part of this guidance, recommended drug dosages have also been updated based on newly available information.
The RVC says this will ensure that available antimicrobial drugs can be used as responsibly as possible and remain effective for a long as possible.
RVC has also produced a short synopsis of the main consensus statements and a ‘Seven Moments of Responsible Canine Pyoderma Treatment’ infographic.
Anette Loeffler, Professor in Veterinary Dermatology and Cutaneous Bacteriology at the RVC and chair of the ISCAID author group, said: “After several years of analysing evidence, updating information and evaluating experience, we are excited and relieved to finally see the guideline documents published and free to use around the world.”
https://pubmed.ncbi.nlm.nih.gov/40338805